subject: Give up the loss of pharmaceutical industry back to Holley Pharmaceutical Instruments line of work - Holley Pharmaceutical - pharmaceutical industries [print this page] Give up the loss of pharmaceutical industry back to Holley Pharmaceutical Instruments line of work - Holley Pharmaceutical - pharmaceutical industries
Loss per share of 0.17 yuan in 2009 the Chinese legislature will sell loss medicine Medicine Industry seeks rebound. Yesterday, China announced a major matter of legislative medicine, pharmaceutical company intends to sell assets to the Group, thereby traveling light, main attack smart grid instrumentation industries. In this context, restoration of the Holley yesterday closed at the daily limit of medicine, by the close, sealing one still higher than 150 million yuan. Because there is another series Holley two pharmaceutical companies?? Suburban district of Hangzhou people and Kunming Pharmacy , Post restructuring or asset injection by the industry optimistic.
Sell all the assets of Traditional Chinese Medicine
Yesterday, the company announced Holley Pharmaceutical major issues of transformation. The controlling shareholder of the company has a subsidiary of Chinese and western medicine Hualijituan reached an initial intent, Chinese and western medicine all interested in the transferee company holds equity pharmaceutical companies and other medical services related to essential assets. It is estimated that, as of December 31, 2009, the company intention to transfer to the Chinese and western medicine enterprises have accumulated total assets of 317 million yuan, 136 million of total liabilities and net assets of 1.81 yuan. Operating income 198 million yuan, total profit -4,638 million, net -4.15 thousand million.
Present, share transfer issues are still in the intention stage. In this regard, day care who share the view that exit the pharmaceutical industry will help get rid of Holley medicine "burden."
Specializing in smart grid After exiting the pharmaceutical industry, Holley Pharmaceutical future main attack with Sagem Communications Instruments industry. Notably, the company announced the company engaged in clearly defined as smart grid instrument. As the current hot topic, no doubt the company can bring an extraordinary appeal.
According to the announcement, the French company Sagem Communications, a broadband communications, telecommunications and Energy Equipment of the leading manufacturing companies. Holley Holley Pharmaceutical, a subsidiary instrument with Sagem Communications to conduct a comprehensive Cooperation Integrate their superior resources, the formation of a new global company and will strive to become the overall smart grid client management solution providers. According to Holley Pharmaceutical
Annual Report, 2008, after the completion of the overall relocation, a subsidiary of Holley Metering, the advantage of intensive production gradually. Instrument Business 2009 revenues of 1.012 billion yuan, up 19.47%. Gross profit 354 million yuan, accounting for about 90% of the total gross margin.
Holley recombination Make Waves As Hualijituan or suburban district of Hangzhou, Kunming Pharmaceutical's largest shareholder, together with the Chinese and western medicine to the transferee all the medicine Holley Pharmaceutical assets, asset integration Holley Department of Medicine is expected to Make Waves.
Information, Holley Pharmaceutical The proposed transfer of assets, including Artemisinin And the Department of Kunming Pharmaceutical Holley also has artemisinin assets, it will cause a direct competitive situation.
Days congenial Gu pointed out that the legislation had entered the Kunming Pharmaceutical of China, the Yunnan provincial government has promised to Holley drug artemisinin into the Kunming Pharmaceutical Industry. On the other hand, domestic artemisinin API Prices are low, but not by artemisinin preparations as WHO (World Health Organization) certification, only through the informal market Sell , The current sales slow. Some analysts predict that artemisinin assets where to go will be the Department of listed companies Holley suburban district of Hangzhou, Kunming Pharmaceutical of integration opportunities.
background Holley's "self-salvation"
In the industry view, Holley medicine "of his medical training from the table" is a self-salvation. An instrument originally focused on return to old-industry companies.
Information, Holley pharmaceutical company was originally an instrument. In 2000, out of artemisinin market prospects, capital operations, the company entered the pharmaceutical industry. Into a GAP from artemisinin cultivation, raw material medicine extraction, production and sales agents complete industrial chain. May 2004, WHO will be in the past year 100,000 of purchases increased to 4.4 million. Artemisinin triggered price hikes. 2005 and 2006, the artemisinin business for the company bring in huge profits. The growth of pharmaceutical industry, to become the main source of company profits, the company also changed its name to Holley medicine.
